Search Results - "Gheit, H."

817TiP GYNET study - Safety and efficacy of anti-netrin 1 (NP137) in combination with chemotherapy and/or pembrolizumab in patients (pts) with pretreated locally advanced/metastatic endometrial carcinoma or cervix carcinoma: An adaptive multi-arms randomized phase I/II trial by Ray-Coquard, I., Cassier, P., Chabaud, S., Mehlen, P., Bernet, A., Le Bras, F., Gheit, H., Angel, C., Mastier, C., Ducarouge, B., De La Motte Rouge, T., Gladieff, L., Floquet, A., Fabbro, M., Joly, F., Provansal Gross, M., Frenel, J-S., Leary, A., Perol, D., Blay, J-Y.

Get full text

P.398 - Rimeporide: safety, tolerability and pharmacokinetic results from a phase Ib study in DMD boys as well as exploratory biomarkers by Gidaro, T., Servais, L., Previtali, S., Zambon, A., Pitchforth, J., Maresh, K., Diaz, J., Laveille, C., Gray, J., Porte-Thomé, F., Gheit, H., Annoussamy, M., Che, V., Duchene, D., Sora, M., Gerevini, S., Vidal, N., Groves, K., Brimble, J., Muntoni, F.

Get full text

Rimeporide: safety, tolerability and pharmacokinetic results from a phase Ib study in DMD boys as well as exploratory biomarkers by Gidaro, T., Servais, L., Previtali, S., Zambon, A., Pitchforth, J., Maresh, K., Diaz, J., Laveille, C., Gray, J., Porte-Thomé, F., Gheit, H., Annoussamy, M., Che, V., Duchene, D., Sora, M., Gerevini, S., Vidal, N., Groves, K., Brimble, J., Muntoni, F.

Get full text